We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's how to find the best top-ranked value stocks to buy in 2026.
Healthcare stock BTSG soared 230% since its 2024 IPO. Yet it's a great value stock with big growth potential.
No matter what happens in the next few weeks, the bull case for Wall Street remains intact for 2026. Investors should be optimistic heading into next year because earnings are projected to grow significantly, and the Fed is expected to keep lowering interest rates.
That said, some investors might not want to chase technology stocks and AI names right now. Wall Street could start rotating into other pockets of the market to begin 2026 after a blockbuster few years for the AI trade.
Amid growing AI bubble talk, some investors might want to consider buying value stocks.
Let’s explore how investors can screen for the best Zacks Rank #1 (Strong Buy) value stocks to buy in 2026.
Screen Basics for Buying the Best Value Stocks
The screen we are digging into today comes loaded with the Research Wizard and aims to sort through highly-ranked Zacks stocks to find some of the top value names.
This value-focused screen searches only for stocks that boast Zacks Rank #1 (Strong Buys) or #2 (Buys). It also focuses on stocks with price-to-earnings (P/E) ratios under the median for its industry. The screen also looks for stocks with price-to-sales (P/S) ratios under the median for its industry to help lock in relative value compared to its peers, since basing it off the wider market is not always the most useful tool.
The screen then digs into quarterly earnings rates above the median for its industry. This particular Zacks screen also uses a special blend of upgrades and estimates revisions to select the best seven stocks in this list.
The screen basics are listed below…
· Only Zacks Rank #1 (Strong Buy) or #2 (Buy) Stocks
· P/E (using 12-month EPS) - Under the Median for its Industry
· P/S - Under the Median for its Industry
· Percentage Change Act. EPS Q(0)/Q(-1)
· Rating Change and Revisions Factors (to help narrow the list to the 7 best stocks in this list)
This strategy comes loaded with the Research Wizard and it is called bt_sow_value_method1. It can be found in the SoW (Screen of the Week) folder.
The screen is simple, yet powerful. Here is one of the seven stocks that made it through this week's screen…
Buy Soaring Healthcare Stock BTSG for Value and Growth
BrightSpring Health Services, Inc. (BTSG - Free Report) is a major U.S. healthcare company that focuses on providing care and services to people with complex medical needs right in their homes or communities, rather than in hospitals. BrightSpring stock has surged since its IPO in early 2024 on the back of strong earnings and revenue expansion.
Image Source: Zacks Investment Research
BTSG operates across two main lines of business: pharmacy services and provider services. Its pharmacy segment helps deliver specialized medications, while its provider unit is built around home health nursing, physical therapy, behavioral health support, rehabilitation, and beyond.
BrightSpring is projected to expand its sales by 13% in 2025 and 15% in FY26. Better yet, its adjusted earnings are expected to skyrocket 92% in 2025 and another 33% next year to climb from $0.56 in FY24 to $1.42 a share next year.
BTSG has topped our EPS estimate by an average of 45% in the past four months, and its earnings estimates continue to surge. Its FY26 EPS estimate has jumped 11% since its Q3 release to help earn BrightSpring its Zacks Rank #1 (Strong Buy).
Image Source: Zacks Investment Research
The home and community-based health services provider has soared 230% since its debut, including a 33% run to new highs over the last three months, crushing its industry and the S&P 500 in the process. BrightSpring still trades 10% below its average Zacks price target, and it's nearly in line with the benchmark in terms of forward earnings. In terms of forward sales, BTSG trades at 0.45X, offering a discount to its industry despite climbing 230% since its IPO vs. its industry’s -7% decline.
Get the rest of the stocks on this list and start looking for the newest companies that fit these criteria. It's easy to do. And it could help you find your next big winner. Start screening for these companies today with a free trial to the Research Wizard. You can do it.
Want more articles from this author? Scroll up to the top of this article and click the FOLLOW AUTHOR button to get an email each time a new article is published.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Image: Bigstock
The Best Value Stocks to Buy in 2026
Key Takeaways
No matter what happens in the next few weeks, the bull case for Wall Street remains intact for 2026. Investors should be optimistic heading into next year because earnings are projected to grow significantly, and the Fed is expected to keep lowering interest rates.
That said, some investors might not want to chase technology stocks and AI names right now. Wall Street could start rotating into other pockets of the market to begin 2026 after a blockbuster few years for the AI trade.
Amid growing AI bubble talk, some investors might want to consider buying value stocks.
Let’s explore how investors can screen for the best Zacks Rank #1 (Strong Buy) value stocks to buy in 2026.
Screen Basics for Buying the Best Value Stocks
The screen we are digging into today comes loaded with the Research Wizard and aims to sort through highly-ranked Zacks stocks to find some of the top value names.
This value-focused screen searches only for stocks that boast Zacks Rank #1 (Strong Buys) or #2 (Buys). It also focuses on stocks with price-to-earnings (P/E) ratios under the median for its industry. The screen also looks for stocks with price-to-sales (P/S) ratios under the median for its industry to help lock in relative value compared to its peers, since basing it off the wider market is not always the most useful tool.
The screen then digs into quarterly earnings rates above the median for its industry. This particular Zacks screen also uses a special blend of upgrades and estimates revisions to select the best seven stocks in this list.
The screen basics are listed below…
· Only Zacks Rank #1 (Strong Buy) or #2 (Buy) Stocks
· P/E (using 12-month EPS) - Under the Median for its Industry
· P/S - Under the Median for its Industry
· Percentage Change Act. EPS Q(0)/Q(-1)
· Rating Change and Revisions Factors (to help narrow the list to the 7 best stocks in this list)
This strategy comes loaded with the Research Wizard and it is called bt_sow_value_method1. It can be found in the SoW (Screen of the Week) folder.
The screen is simple, yet powerful. Here is one of the seven stocks that made it through this week's screen…
Buy Soaring Healthcare Stock BTSG for Value and Growth
BrightSpring Health Services, Inc. (BTSG - Free Report) is a major U.S. healthcare company that focuses on providing care and services to people with complex medical needs right in their homes or communities, rather than in hospitals. BrightSpring stock has surged since its IPO in early 2024 on the back of strong earnings and revenue expansion.
Image Source: Zacks Investment Research
BTSG operates across two main lines of business: pharmacy services and provider services. Its pharmacy segment helps deliver specialized medications, while its provider unit is built around home health nursing, physical therapy, behavioral health support, rehabilitation, and beyond.
BrightSpring is projected to expand its sales by 13% in 2025 and 15% in FY26. Better yet, its adjusted earnings are expected to skyrocket 92% in 2025 and another 33% next year to climb from $0.56 in FY24 to $1.42 a share next year.
BTSG has topped our EPS estimate by an average of 45% in the past four months, and its earnings estimates continue to surge. Its FY26 EPS estimate has jumped 11% since its Q3 release to help earn BrightSpring its Zacks Rank #1 (Strong Buy).
Image Source: Zacks Investment Research
The home and community-based health services provider has soared 230% since its debut, including a 33% run to new highs over the last three months, crushing its industry and the S&P 500 in the process. BrightSpring still trades 10% below its average Zacks price target, and it's nearly in line with the benchmark in terms of forward earnings. In terms of forward sales, BTSG trades at 0.45X, offering a discount to its industry despite climbing 230% since its IPO vs. its industry’s -7% decline.
Get the rest of the stocks on this list and start looking for the newest companies that fit these criteria. It's easy to do. And it could help you find your next big winner. Start screening for these companies today with a free trial to the Research Wizard. You can do it.
Click here to sign up for a free trial to the Research Wizard today.
Want more articles from this author? Scroll up to the top of this article and click the FOLLOW AUTHOR button to get an email each time a new article is published.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Disclosure: Performance information for Zacks’ portfolios and strategies are available at: www.zacks.com/performance_disclosure